Ribosomal activation in TNBC resistance in vitro.
Fuente:
Zenodo
Enregistré dans:
| Auteur principal: | Mamoor, Shahan |
|---|---|
| Format: | Recurso digital |
| Publié: |
Zenodo
2025
|
| Accès en ligne: | |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
Xist is activated during resistance in triple negative breast cancer in vitro.
par: Mamoor, Shahan
Publié: (2025)
par: Mamoor, Shahan
Publié: (2025)
Therapeutic targeting in androgen receptor-positive triple negative breast cancer (AR+ TNBC): THTPA.
par: Mamoor, Shahan
Publié: (2025)
par: Mamoor, Shahan
Publié: (2025)
Therapeutic targeting in androgen receptor-negative triple negative breast cancer (AR- TNBC): HUNK.
par: Mamoor, Shahan
Publié: (2025)
par: Mamoor, Shahan
Publié: (2025)
Therapeutic targeting in androgen receptor positive triple negative breast cancer (AR+ TNBC): FGR.
par: Mamoor, Shahan
Publié: (2025)
par: Mamoor, Shahan
Publié: (2025)
Therapeutic targeting in androgen receptor positive triple negative breast cancer (AR+ TNBC): PINK1.
par: Mamoor, Shahan
Publié: (2025)
par: Mamoor, Shahan
Publié: (2025)
Therapeutic targeting in androgen receptor positive triple negative breast cancer (AR+ TNBC): GRK3.
par: Mamoor, Shahan
Publié: (2025)
par: Mamoor, Shahan
Publié: (2025)
SLX1B is active during transformation and controls relapse and resistance in human cancer.
par: Mamoor, Shahan
Publié: (2025)
par: Mamoor, Shahan
Publié: (2025)
ABCA12 functions in multi-drug resistance in human cancer.
par: Mamoor, Shahan
Publié: (2025)
par: Mamoor, Shahan
Publié: (2025)
Matrix metalloproteinases MMP1/MMP9 function in melanoma resistance.
par: Mamoor, Shahan
Publié: (2025)
par: Mamoor, Shahan
Publié: (2025)
Glucocorticoid resistance features changes in general transcription factor (GTF) expression.
par: Mamoor, Shahan
Publié: (2025)
par: Mamoor, Shahan
Publié: (2025)
An expression screen to identify genes important for trastuzumab resistance: Ccl19.
par: Mamoor, Shahan
Publié: (2026)
par: Mamoor, Shahan
Publié: (2026)
An expression screen to identify genes important for trastuzumab resistance: Meox2.
par: Mamoor, Shahan
Publié: (2026)
par: Mamoor, Shahan
Publié: (2026)
ABCG2 functions in multi-drug resistance in human cancer in metastasis to the bone.
par: Mamoor, Shahan
Publié: (2025)
par: Mamoor, Shahan
Publié: (2025)
An expression screen to identify genes important for trastuzumab resistance: Pax8-as1.
par: Mamoor, Shahan
Publié: (2026)
par: Mamoor, Shahan
Publié: (2026)
Adirf activation in chronic disease.
par: Mamoor, Shahan
Publié: (2025)
par: Mamoor, Shahan
Publié: (2025)
PAXX is activated in aging blood cells.
par: Mamoor, Shahan
Publié: (2025)
par: Mamoor, Shahan
Publié: (2025)
Chemokine activation during cellular senescence.
par: Mamoor, Shahan
Publié: (2024)
par: Mamoor, Shahan
Publié: (2024)
ABC transporter multi-drug resistance genes ("pumps") in humans with non-small cell lung cancer.
par: Mamoor, Shahan
Publié: (2025)
par: Mamoor, Shahan
Publié: (2025)
Importin 8 is activated in childhood brain cancer.
par: Mamoor, Shahan
Publié: (2025)
par: Mamoor, Shahan
Publié: (2025)
Leukotriene activation in the blood of humans with high CRP.
par: Mamoor, Shahan
Publié: (2025)
par: Mamoor, Shahan
Publié: (2025)
ALOX15B activation in ulcerative colitis.
par: Mamoor, Shahan
Publié: (2025)
par: Mamoor, Shahan
Publié: (2025)
Alox5 activation in the blood of humans with high CRP.
par: Mamoor, Shahan
Publié: (2025)
par: Mamoor, Shahan
Publié: (2025)
Gasdermin activation during lineage specification in the human embryo.
par: Mamoor, Shahan
Publié: (2026)
par: Mamoor, Shahan
Publié: (2026)
TSC22D4 gene activation in Crohn's Disease.
par: Mamoor, Shahan
Publié: (2025)
par: Mamoor, Shahan
Publié: (2025)
NLRP11 detects activation of CIDE cell death effectors.
par: Mamoor, Shahan
Publié: (2025)
par: Mamoor, Shahan
Publié: (2025)
Arid5b is activated early in human embryonic development.
par: Mamoor, Shahan
Publié: (2026)
par: Mamoor, Shahan
Publié: (2026)
Ep300 activation defines a common epigenetic route in chronic disease.
par: Mamoor, Shahan
Publié: (2025)
par: Mamoor, Shahan
Publié: (2025)
Feedback activation of VEGF-A resulting from PAX8 inhibition in cancer cells.
par: Mamoor, Shahan
Publié: (2026)
par: Mamoor, Shahan
Publié: (2026)
Fam234b is selectively activated during the first cell division of the human embryo.
par: Mamoor, Shahan
Publié: (2026)
par: Mamoor, Shahan
Publié: (2026)
The homeobox transcription factor TCF7 is activated in and likely required for metastasis to the lymph nodes in humans with breast cancer.
par: Mamoor, Shahan
Publié: (2025)
par: Mamoor, Shahan
Publié: (2025)
The homeobox transcription factor MEOX1 is activated in and likely required for metastasis to the lymph nodes in humans with breast cancer.
par: Mamoor, Shahan
Publié: (2025)
par: Mamoor, Shahan
Publié: (2025)
Kinase activation during small molecule inhibition of the receptors for the vascular endothelial growth factors VEGFR1 and VEGFR2.
par: Mamoor, Shahan
Publié: (2025)
par: Mamoor, Shahan
Publié: (2025)
The integral membrane protein SMIM38 is transcriptionally activated in circulating tumor cells in human breast cancer in conjunction with two SMIM38-interacting proteins of undefined function, ETDA and ETDB.
par: Mamoor, Shahan
Publié: (2025)
par: Mamoor, Shahan
Publié: (2025)
NLRP7 engagement in transformation and etiology of chronic disease.
par: Mamoor, Shahan
Publié: (2025)
par: Mamoor, Shahan
Publié: (2025)
The range of Xist transcriptional targets in non-small cell lung cancer: BTBD7.
par: Mamoor, Shahan
Publié: (2025)
par: Mamoor, Shahan
Publié: (2025)
Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: AIM1.
par: Mamoor, Shahan
Publié: (2025)
par: Mamoor, Shahan
Publié: (2025)
Therapeutic targeting in colorectal cancer for the treatment of the primary tumor: TGFBI.
par: Mamoor, Shahan
Publié: (2025)
par: Mamoor, Shahan
Publié: (2025)
Therapeutic targeting in breast cancer for the treatment of liver metastasis: AFM.
par: Mamoor, Shahan
Publié: (2025)
par: Mamoor, Shahan
Publié: (2025)
Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: MTF1.
par: Mamoor, Shahan
Publié: (2025)
par: Mamoor, Shahan
Publié: (2025)
Therapeutic targeting in colorectal cancer for the treatment of the primary tumor: MAT1A.
par: Mamoor, Shahan
Publié: (2025)
par: Mamoor, Shahan
Publié: (2025)
Documents similaires
-
Xist is activated during resistance in triple negative breast cancer in vitro.
par: Mamoor, Shahan
Publié: (2025) -
Therapeutic targeting in androgen receptor-positive triple negative breast cancer (AR+ TNBC): THTPA.
par: Mamoor, Shahan
Publié: (2025) -
Therapeutic targeting in androgen receptor-negative triple negative breast cancer (AR- TNBC): HUNK.
par: Mamoor, Shahan
Publié: (2025) -
Therapeutic targeting in androgen receptor positive triple negative breast cancer (AR+ TNBC): FGR.
par: Mamoor, Shahan
Publié: (2025) -
Therapeutic targeting in androgen receptor positive triple negative breast cancer (AR+ TNBC): PINK1.
par: Mamoor, Shahan
Publié: (2025)